E-cigarette, or vaping, product use Associated Lung Injury (EVALI): new scenarios for physicians and radiologists.
Monaldi Arch Chest Dis
; 92(3)2021 Dec 03.
Article
em En
| MEDLINE
| ID: mdl-34865457
A 59-year-old female ex-smoker with 40 pack year smoking history and a 5-year current e-cigarette (EC) use history, presented with progressive dyspnea on exertion and daily cough for 2 months. A CT scan showed a consolidation area with air bronchogram in the middle lobe and non-calcific bilateral nodules, which could be attributed to community-acquired pneumonia. The patient was treated with empiric antibiotics and systemic steroids for 10 days. Infectious, neoplastic and autoimmune pathologies were excluded, whereas a broncho-alveolar lavage revealed an accumulation of lipids in the cytoplasm of the alveolar macrophages. Despite the recommendation of vaping cessation, the patient continued to use EC. A new CT exam, carried out after 18 months, showed reversed halo sign (RHS), patchy ground-glass opacity (GGO), pleuro-parenchymal bands, and indeed perilobular pattern, suggestive of organizing pneumonia (OP). The final diagnosis was E-cigarette, or vaping, product use Associated Lung Injury (EVALI)- related OP.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Médicos
/
Pneumonia
/
Lesão Pulmonar
/
Sistemas Eletrônicos de Liberação de Nicotina
/
Vaping
Tipo de estudo:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Monaldi Arch Chest Dis
Ano de publicação:
2021
Tipo de documento:
Article